Review



human interleukin duoset elisa development systems  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems human interleukin duoset elisa development systems
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Human Interleukin Duoset Elisa Development Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human interleukin duoset elisa development systems/product/R&D Systems
    Average 93 stars, based on 108 article reviews
    human interleukin duoset elisa development systems - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Therapeutic Potential of a Natural Blend of Aronia melancarpa , Lonicera caerulea , and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights"

    Article Title: Therapeutic Potential of a Natural Blend of Aronia melancarpa , Lonicera caerulea , and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms252413436

    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 (Interleukin-6), IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Figure Legend Snippet: The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 (Interleukin-6), IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).

    Techniques Used: Concentration Assay, Activity Assay, Capsules

    The impact of the ELA blend on immune system indicators in patients receiving the ELA blend in the form of syrup. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL (Interleukin)-6, IL-1β, and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Figure Legend Snippet: The impact of the ELA blend on immune system indicators in patients receiving the ELA blend in the form of syrup. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL (Interleukin)-6, IL-1β, and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).

    Techniques Used: Concentration Assay, Activity Assay



    Similar Products

    human interleukin duoset elisa development systems  (R&D Systems)
    93
    R&D Systems human interleukin duoset elisa development systems
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Human Interleukin Duoset Elisa Development Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human interleukin duoset elisa development systems/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human interleukin duoset elisa development systems - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    il 6 duoset elisa development systems  (R&D Systems)
    96
    R&D Systems il 6 duoset elisa development systems
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Il 6 Duoset Elisa Development Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 6 duoset elisa development systems/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    il 6 duoset elisa development systems - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    duoset elisa development systems  (R&D Systems Hematology)
    90
    R&D Systems Hematology duoset elisa development systems
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Duoset Elisa Development Systems, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/duoset elisa development systems/product/R&D Systems Hematology
    Average 90 stars, based on 1 article reviews
    duoset elisa development systems - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    duoset elisa development kits  (R&D Systems)
    96
    R&D Systems duoset elisa development kits
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Duoset Elisa Development Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/duoset elisa development kits/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    duoset elisa development kits - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    immunosorbent assay elisa development systems  (R&D Systems)
    96
    R&D Systems immunosorbent assay elisa development systems
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Immunosorbent Assay Elisa Development Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunosorbent assay elisa development systems/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    immunosorbent assay elisa development systems - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    duoset elisa development system  (R&D Systems)
    96
    R&D Systems duoset elisa development system
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Duoset Elisa Development System, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/duoset elisa development system/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    duoset elisa development system - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    human betacellulin duoset elisa development system  (R&D Systems)
    93
    R&D Systems human betacellulin duoset elisa development system
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Human Betacellulin Duoset Elisa Development System, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human betacellulin duoset elisa development system/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human betacellulin duoset elisa development system - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    human tie1 duoset elisa development system  (R&D Systems)
    93
    R&D Systems human tie1 duoset elisa development system
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Human Tie1 Duoset Elisa Development System, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human tie1 duoset elisa development system/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human tie1 duoset elisa development system - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    duoset elisa development kit  (R&D Systems)
    96
    R&D Systems duoset elisa development kit
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Duoset Elisa Development Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/duoset elisa development kit/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    duoset elisa development kit - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    duoset elisa development systems  (R&D Systems)
    96
    R&D Systems duoset elisa development systems
    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 <t> (Interleukin-6), </t> IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).
    Duoset Elisa Development Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/duoset elisa development systems/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    duoset elisa development systems - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 (Interleukin-6), IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).

    Journal: International Journal of Molecular Sciences

    Article Title: Therapeutic Potential of a Natural Blend of Aronia melancarpa , Lonicera caerulea , and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights

    doi: 10.3390/ijms252413436

    Figure Lengend Snippet: The impact of the ELA blend on immune system indicators compared to the placebo group. The study period spans from day D0 to D60. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL-6 (Interleukin-6), IL-1β (Interleukin-1 beta), and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).

    Article Snippet: Cytokine levels in the supernatants were measured using Human Interleukin DuoSet ® ELISA Development Systems (R&D Systems, Inc., Minneapolis, MN, USA), following the manufacturer’s instructions.

    Techniques: Concentration Assay, Activity Assay, Capsules

    The impact of the ELA blend on immune system indicators in patients receiving the ELA blend in the form of syrup. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL (Interleukin)-6, IL-1β, and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).

    Journal: International Journal of Molecular Sciences

    Article Title: Therapeutic Potential of a Natural Blend of Aronia melancarpa , Lonicera caerulea , and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights

    doi: 10.3390/ijms252413436

    Figure Lengend Snippet: The impact of the ELA blend on immune system indicators in patients receiving the ELA blend in the form of syrup. The dataset includes measurements of serum CRP concentration (C-Reactive Protein), SOD activity (Superoxide Dismutase), and the production of cytokines such as IFN-α (Interferon-alpha), IL (Interleukin)-6, IL-1β, and TNF-α (Tumor Necrosis Factor-alpha) in PBMCs (Peripheral Blood Mononuclear Cells) stimulated with PHA-L (Phytohemagglutinin-L) or R848 (Resiquimod). Statistical evaluations are represented through Median (Me), Median of Differences (MEDIAN OF DIFF.), Interquartile Range (IQR), Confidence Interval (CI), and p -values ( p ).

    Article Snippet: Cytokine levels in the supernatants were measured using Human Interleukin DuoSet ® ELISA Development Systems (R&D Systems, Inc., Minneapolis, MN, USA), following the manufacturer’s instructions.

    Techniques: Concentration Assay, Activity Assay